Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Post Graduate Institute of Medical Education and Research (pgimer)
Chandigarh, India
- Medanta - the Medicity Hospital
Gurugramam, India
- Max Super Specialty Hospital
New Delhi, India
- Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (jipmer)
Puducherry, India
- Sp Zoz Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi, Klinika Nefrologii, Hipertensjologii
Lodz, Poland
- Miedzyleski Szpital Specjalistyczny W Warszawie, Oddzial Nefrologiczny I Stacja Dializ
Warsaw, Poland
- Akdhc Medical Research Services, Llc
Sun City, Arizona, United States
- California Institute of Renal Research
Chula Vista, California, United States
- University of California San Diego Perlman Ambulatory Clinic
La Jolla, California, United States
- Clinical Research of West Florida - Clearwater
Clearwater, Florida, United States
- Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, Florida, United States
- University of Florida, Division of Rheumatology
Gainesville, Florida, United States
- Clinical Site Partners Leesburg, Llc
Leesburg, Florida, United States
- Hope Clinical Trials
Miami, Florida, United States
- Southcoast Research Center Inc
Miami, Florida, United States
- Omega Research Maitland, Llc
Orlando, Florida, United States
- Clinical Research of West Florida - Tampa
Tampa, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Georgia Nephrology
Lawrenceville, Georgia, United States
- Northwell Health / Division of Rheumatology
Great Neck, New York, United States
- Columbia University Medical Center, Div of Nephrology
New York, New York, United States
- Albert Einstein College of Medicine, Montefiore Medical Center
The Bronx, New York, United States
- Northeast Clinical Research Center, Llc
Bethlehem, Pennsylvania, United States
- Dallas Renal Group
Dallas, Texas, United States
- Prolato Clinical Research Center (pcrc)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2019
- Primary completion
- 16 Nov 2023
- Completion
- 18 Jan 2024
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 52
- Registry id
- NCT04128579
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.